Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam). (Q51584281)

From Wikidata

Jump to navigation Jump to search

scientific article published on 29 March 2011

Language	Label	Description	Also known as
English	Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam).	scientific article published on 29 March 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Identifying and characterizing "escapes"-men who develop metastases or die from prostate cancer despite screening (ERSPC, section Rotterdam) (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

author name string

Xiaoye Zhu

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Pim J van Leeuwen

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Meelan Bul

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Chris H Bangma

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Fritz H Schröder

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

language of work or name

0 references

publication date

29 March 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

129

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

2847-2854

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21448904%20AND%20SRC:MED&resulttype=core&format=json

27 January 2020

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Prostate cancer mortality reduction by prostate-specific antigen-based screening adjusted for nonattendance and contamination in the European Randomised Study of Screening for Prostate Cancer (ERSPC)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Survival results in patients with screen-detected prostate cancer versus physician-referred patients treated with radical prostatectomy: early results

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Under diagnosis and over diagnosis of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

The early detection of prostate carcinoma with prostate specific antigen: the Washington University experience

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Features and preliminary results of the Dutch centre of the ERSPC (Rotterdam, the Netherlands).

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Eleven-year outcome of patients with prostate cancers diagnosed during screening after initial negative sextant biopsies.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

The story of the European Randomized Study of Screening for Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

High-risk prostate cancer in the United States, 1990-2007

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

A risk-based strategy improves prostate-specific antigen-driven detection of prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Comparison of screen detected and clinically diagnosed prostate cancer in the European randomized study of screening for prostate cancer, section rotterdam.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Mammographic screening and disease presentation of breast cancer patients who die of disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Minimal impact of clinical stage on prostate cancer prognosis among contemporary patients with clinically localized disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

An extended 10-core transrectal ultrasonography guided prostate biopsy protocol improves the detection of prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Radical prostatectomy in men aged >or=70 years: effect of age on upgrading, upstaging, and the accuracy of a preoperative nomogram

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Risk of dying from prostate cancer in men randomized to screening: differences between attendees and nonattendees.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Interval cancers in prostate cancer screening: comparing 2- and 4-year screening intervals in the European Randomized Study of Screening for Prostate Cancer, Gothenburg and Rotterdam

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Adjuvant radiotherapy after radical prostatectomy: indications, results and side effects

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Effect of the correction for noncompliance and contamination on the estimated reduction of metastatic prostate cancer within a randomized screening trial (ERSPC section Rotterdam)

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Defining Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy: A Proposal for a Standardized Definition

1 reference

https://api.crossref.org/works/10.1002%2FIJC.25947

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51584281&oldid=1237368676"